- Home
- BCRX vs FSM Comparison
BCRX vs FSM Comparison
Compare BCRX & FSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BCRX | FSM |
|---|---|---|
| Founded | 1986 | 1990 |
| Country | United States | Canada |
| Employees | N/A | 1633 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 3.5B |
| IPO Year | 1995 | 2005 |
Fundamental Metrics
Financial Performance| Metric | BCRX | FSM |
|---|---|---|
| Price | $8.83 | $11.80 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 1 |
| Target Price | ★ $20.82 | $14.00 |
| AVG Volume (30 Days) | 3.8M | ★ 4.1M |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 381.40 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $25,186,000.00 | N/A |
| Revenue This Year | N/A | $38.01 |
| Revenue Next Year | $12.55 | N/A |
| P/E Ratio | ★ N/A | $14.10 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $6.00 | $7.69 |
| 52 Week High | $11.22 | $13.85 |
Technical Indicators
Market Signals| Indicator | BCRX | FSM |
|---|---|---|
| Relative Strength Index (RSI) | 44.34 | 52.87 |
| Support Level | $8.79 | $11.56 |
| Resistance Level | $10.05 | $12.74 |
| Average True Range (ATR) | 0.32 | 0.39 |
| MACD | -0.06 | -0.16 |
| Stochastic Oscillator | 35.29 | 29.36 |
Price Performance
Historical ComparisonAbout BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
About FSM Fortuna Silver Mines Inc (Canada)
Fortuna Mining Corp is a Canadian-based precious metals mining company with mines in the Latin America and West Africa regions producing gold and silver. It operate mines in Argentina, Burkina Faso, Cote d'voire, Mexico, and Peru. The company's segment consists of Mansfield, Sango, Bateas, Corporate. The company generates the majority of its revenue from Sango segment which operates the Seguela gold mine. Geographically, the company generates the majority of its revenue from Cote d' Ivoire location.